NovoCure discloses CEO Frank Leonard's pay: CHF 750K base, 90% target bonus, enhanced severance

NovoCure Ltd

Base salary of CHF 750,000 and target annual bonus of 90% of base (CHF 675,000).
Eligible for equity awards under 2024 Omnibus Incentive Plan; relocation and tax indemnification provided.
Severance on qualifying termination: 100% base salary; within 12 months post-change-in-control: 200% base + 200% target bonus plus full equity vesting.
Non-compete covenant for 12 months after termination; perpetual non-disparagement.
Amendment filed to supplement Dec. 1, 2025 8-K; compensation details now finalized.

item 5.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.